Your session is about to expire
← Back to Search
Probiotic for Gastrointestinal Health
Study Summary
The primary objective of this study is to investigate the effect of an oral probiotic (Bacillus sp. spore preparation) on abdominal bloating, flatulence, and burping in generally healthy adults. Secondary outcomes include intestinal barrier integrity and fecal microbiome properties (taxonomical structure, diversity, and function).
- Gastrointestinal Health
- Immune Health
- Digestive Health
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
To whom is admittance to this experiment open?
"Patients must satisfy the digestive health criteria and fall between 30-65 years old to be eligible for this study. Approximately 80 people are being recruited in total."
How many participants is this experiment limited to?
"Indeed, clinicaltrials.gov confirms that this study is in the process of enrolling patients. It was first listed on September 19th 2022 and most recently updated on October 24th 2022. Researchers are aiming to recruit 80 people from one medical centre."
What is the current status of patient recruitment for this research endeavor?
"Affirmative. The clinical trial profile hosted on the website clinicaltrials.gov attests to this study's active recruitment status, with a first post date of September 19th 2022 and an update as recent as October 24th 2022. Currently, 80 volunteers are being sought out from one medical facility."
Is this experiment open to individuals under the age of 70?
"This research is calling for volunteers who are between 30 and 65 years old."
Share this study with friends
Copy Link
Messenger